Paired Associative Stimulation in Methamphetamine Addiction
The Mechanisms of Cortico-cortical and Cortico-subcortical Networks in Methamphetamine Addiction by Paired Associative Stimulation
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200000
- Haifeng Jiang
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- In accordance with the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) for methamphetamine (MA) use disorders
- Junior high school degree or above
- Normal vision and hearing
- Dextromanual
Exclusion Criteria:
- Have a disease that affect cognitive function such as history of head injury, cerebrovascular disease, epilepsy, etc
- Have cognitive-promoting drugs in the last 6 months
- Other substance abuse or dependence in recent five years (except nicotine)
- Mental impairment, Intelligence Quotient (IQ) < 70
- Mental disorders
- Physical disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: DLPFC+10 IPL
Stimulation of dorsolateral prefrontal cortex (DLPFC) 10 ms before inferior parietal lobule (IPL) presumes that the DLPFC to IPL input facilitates insula postsynaptic output activity, thereby improving cognition response via a long term potentiation-like effect.
|
Each cPAS experimental session contained 100 pairs of stimuli at 0.2 Hz.
The experimental conditions differed in the interstimulus interval of the paired pulses.
DLPFC stimulation precedes IPL/MPFC stimulation by 10 ms (DLPFC+10) or by 4 ms (DLPFC+4), and IPL/MPFC stimulation precedes DLPFC stimulation by 4 ms (IPL/MPFC+4) or by 10 ms (IPL+10).
|
|
Experimental: IPL+10 DLPFC
Stimulation of IPL 10 ms before DLPFC presumes that the IPL to DLPFC input inhibits insula postsynaptic output activity, thereby impairing cognition response via a long term depression-like effect.
|
Each cPAS experimental session contained 100 pairs of stimuli at 0.2 Hz.
The experimental conditions differed in the interstimulus interval of the paired pulses.
DLPFC stimulation precedes IPL/MPFC stimulation by 10 ms (DLPFC+10) or by 4 ms (DLPFC+4), and IPL/MPFC stimulation precedes DLPFC stimulation by 4 ms (IPL/MPFC+4) or by 10 ms (IPL+10).
|
|
Experimental: IPL+4 DPLFC
Stimulation of IPL 4 ms before DLPFC is presumed to be too brief for a corticocortical effect but presumes that the DLPFC input to insula inhibits insula postsynaptic output by weakening the IPL to insula input, thereby impairing cognition response.
|
Each cPAS experimental session contained 100 pairs of stimuli at 0.2 Hz.
The experimental conditions differed in the interstimulus interval of the paired pulses.
DLPFC stimulation precedes IPL/MPFC stimulation by 10 ms (DLPFC+10) or by 4 ms (DLPFC+4), and IPL/MPFC stimulation precedes DLPFC stimulation by 4 ms (IPL/MPFC+4) or by 10 ms (IPL+10).
|
|
Experimental: DLPFC+4 IPL
Stimulation of DLPFC 4 ms before IPL is presumed to be too brief for a corticocortical effect but presumes that the DLPFC input to insula potentiates insula postsynaptic output by strengthening the IPL to insula input, thereby improving cognition response.
|
Each cPAS experimental session contained 100 pairs of stimuli at 0.2 Hz.
The experimental conditions differed in the interstimulus interval of the paired pulses.
DLPFC stimulation precedes IPL/MPFC stimulation by 10 ms (DLPFC+10) or by 4 ms (DLPFC+4), and IPL/MPFC stimulation precedes DLPFC stimulation by 4 ms (IPL/MPFC+4) or by 10 ms (IPL+10).
|
|
Experimental: DLPFC+4 MPFC
Stimulation of DLPFC 4 ms before medial prefrontal cortex (MPFC) presumes that the DLPFC input facilitates MPFC postsynaptic output activity, thereby improving cognition response via a long term potentiation-like effect.
|
Each cPAS experimental session contained 100 pairs of stimuli at 0.2 Hz.
The experimental conditions differed in the interstimulus interval of the paired pulses.
DLPFC stimulation precedes IPL/MPFC stimulation by 10 ms (DLPFC+10) or by 4 ms (DLPFC+4), and IPL/MPFC stimulation precedes DLPFC stimulation by 4 ms (IPL/MPFC+4) or by 10 ms (IPL+10).
|
|
Experimental: MPFC+4 DLPFC
Stimulation of MPFC 4 ms before DLPFC presumes that the DLPFC input inhibits MPFC postsynaptic output activity, thereby impairing cognition response via a long term depression-like effect.
|
Each cPAS experimental session contained 100 pairs of stimuli at 0.2 Hz.
The experimental conditions differed in the interstimulus interval of the paired pulses.
DLPFC stimulation precedes IPL/MPFC stimulation by 10 ms (DLPFC+10) or by 4 ms (DLPFC+4), and IPL/MPFC stimulation precedes DLPFC stimulation by 4 ms (IPL/MPFC+4) or by 10 ms (IPL+10).
|
|
Experimental: DLPFC+10 MPFC
Stimulation of DLPFC 10 ms before medial prefrontal cortex (MPFC) presumes that the DLPFC input facilitates MPFC postsynaptic output activity, thereby improving cognition response via a long term potentiation-like effect.
|
Each cPAS experimental session contained 100 pairs of stimuli at 0.2 Hz.
The experimental conditions differed in the interstimulus interval of the paired pulses.
DLPFC stimulation precedes IPL/MPFC stimulation by 10 ms (DLPFC+10) or by 4 ms (DLPFC+4), and IPL/MPFC stimulation precedes DLPFC stimulation by 4 ms (IPL/MPFC+4) or by 10 ms (IPL+10).
|
|
Experimental: MPFC+10 DLPFC
Stimulation of MPFC 10 ms before DLPFC presumes that the DLPFC input inhibits MPFC postsynaptic output activity, thereby impairing cognition response via a long term depression-like effect.
|
Each cPAS experimental session contained 100 pairs of stimuli at 0.2 Hz.
The experimental conditions differed in the interstimulus interval of the paired pulses.
DLPFC stimulation precedes IPL/MPFC stimulation by 10 ms (DLPFC+10) or by 4 ms (DLPFC+4), and IPL/MPFC stimulation precedes DLPFC stimulation by 4 ms (IPL/MPFC+4) or by 10 ms (IPL+10).
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of working memory
Time Frame: 30 minutes
|
The N-Back is a working memory task where the subject is presented with a sequence of stimuli (letters).
The task consists of indicating when the current stimulus matches the one from n steps earlier in the sequence.
|
30 minutes
|
|
Change of response inhibition
Time Frame: 30 minutes
|
Response inhibition was assessed with the SST (Cambridge Cognition, Cambridge, UK).
The subject responded to an arrow (go signal), pointing either right or left, by pressing one of two buttons with the right or left index finger.
If an audio tone (stop signal) was present, the subject needed to withhold the response.
|
30 minutes
|
|
Change of attention bias
Time Frame: 30 minutes
|
During the dot-probe task, participants are situated in front of a computer screen with their chin securely placed on a chin rest.
Participants are asked to stare at a fixation cross on the center of the screen.
Two stimuli, one of which is neutral and one of which is threatening, appear randomly on either side of the screen.
The stimuli are presented for a predetermined length of time (most commonly 500ms), before a dot is presented in the location of one former stimulus.
Participants are instructed to indicate the location of this dot as quickly as possible, either via keyboard or response box.
|
30 minutes
|
|
Change of risk decision
Time Frame: 30 minutes
|
The Balloon Analogue Risk Task (BART) is a computerized measure of risk taking behavior.
In the task, the participant is presented with a balloon and offered the chance to earn money by pumping the balloon up by clicking a button.
Each click causes the balloon to incrementally inflate and money to be added to a counter up until some threshold, at which point the balloon is over inflated and explodes.
|
30 minutes
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of eeg oscillatory (Alpha, Beta, Theta and Delta)
Time Frame: 30 minutes
|
EEG was recorded to evaluate the changes in the oscillatory domain before and after the stimulation.
|
30 minutes
|
|
Change of eeg functional connectivity (Alpha, Beta, Theta and Delta)
Time Frame: 30 minutes
|
EEG was recorded to evaluate the changes of functional connectivity before and after the stimulation.
|
30 minutes
|
|
Change of motor evoked potential
Time Frame: 30 minutes
|
Single-pulse TMS will be used to evoke a motor response that is recorded using electromyography (EMG).
The peak-to-peak amplitude of the EMG response will be measured.
|
30 minutes
|
|
Change of resting motor threshold
Time Frame: 30 minutes
|
Single-pulse TMS will be used to evoke a motor response that is recorded using electromyography (EMG).
The lowest stimulator output needed to elicit a consistent response will be recorded.
|
30 minutes
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Haifeng Jiang, PhD, Shanghai Mental Health Center
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- HFJiang-003
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.